Showing: 1 - 10 of 10 RESULTS
Briefing Bright Minds Biosciences Ian McDonald Psychedelics The Daily Dive Video Series

Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising results of the company’s proprietary BMB-101 drug to treat a rare form of epilepsy, Dravet Syndrome. The chief officer also talks about the firm’s plan to list on the Nasdaq, the common misconceptions on psychedelics, …

Briefing Bright Minds Biosciences Gideon Shapiro Psychedelics The Daily Dive Video Series

Bright Minds: Focusing On Second Generation Psychedelic Compounds – The Daily Dive

Starting off this week on the Daily Dive is that of Dr Gideon Shapiro, whom is VP of Discovery at Bright Minds Biosciences (CSE: DRUG). A leading scientist in the field of creating novel psychedelics to treat mental health disorders, Dr Shapiro joins us this afternoon to provide us with a deeper understanding of seratonin …

Adam Deffett Briefing Healthcare KetamineOne Capital Psychedelics The Daily Dive Video Series

Ketamine One: Developing A Network of Mental Health Clinics – The Daily Dive

Today on the Daily Dive, we are joined by Adam Deffett, VP of Capital Markets for KetamineOne Capital (NEO: MEDI). Adam, joins us this afternoon to discuss the strategy behind Ketamine One and how it relates to recent acquisitions, the move to the NEO exchange, IVR therapies, and the future of the ketamine space as …

Briefing Jeff Stevens Psyched Wellness Psychedelics The Daily Dive Video Series

Psychedelics: Sector Tailwinds To Come – The Daily Dive feat Psyched Wellness CEO Jeff Stevens

Starting off the short Canadian trading week this week on the Daily Dive is that of Jeff Stevens, CEO of Psyched Wellness (CSE: PSYC). Jeff joins us to discuss the latest developments across the psychedelics sector as a whole and coming tailwinds, as well as the current progress that Psyched is making in commercializing the …

Briefing Bright Minds Biosciences Ian McDonald Psychedelics The Daily Dive Video Series

Bright Minds: The Next Revolution In Mental Health Care – The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). Ian joins us today to give the two minute elevator pitch for his company, to give his take on what separates the real operators from the pretenders within the psychedelics space, and to discuss …

Amanita Muscaria Briefing Compass Pathways Professor David Nutt Psyched Wellness Psychedelics The Daily Dive Video Series

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt, a highly experienced neuropsychopharmacologist, the chair of the scientific advisory board for Compass Pathways (NASDAQ: CMPS), and a director of Psyched Wellness (CSE: PSYC). David joins us this morning to discuss psychedelics and the science behind it, clinical research, and …

Briefing Compass Pathways Jeff Stevens Psyched Wellness Psychedelics The Daily Dive Video Series

Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens

Today on the Daily Dive, Jeff Stevens returns to the show to sit down with host Cassandra Leah to discuss that of Psyched Wellness (CSE: PSYC), where he currently serves as CEO. In the latest edition of the Daily Dive, we ask Jeff about that of Compass Pathways, the psychedelics sector as a whole and …

Ben Nikolaevsky Briefing Cannabis Psychedelics Pure Extracts The Daily Dive Video Series

Taking On The Functional Mushroom Market – The Daily Dive Feat Ben Nikolaevsky Of Pure Extracts

Ben Nikolaevsky of Pure Extracts (CSE: PULL) returns to The Daily Dive for this afternoon’s episode. He sits down with our host Cassandra Leah to discuss the functional mushroom market and the firms involvement within the growing space. Ben focuses exclusively on the functional mushroom market, referring to its as the “CBD of 2020.” Pure, …

Briefing Psyched Wellness Psychedelics The Daily Dive Video Series

Daily Dive: Shroom Stocks About To Fly? With Jeff Stevens, CEO Of Psyched Wellness

Today on The Daily Dive we have Jeff Stevens, CEO of Psyched Wellness (CSE: PSYC). Jeff sits down with our host, Cassandra Leah, to discuss the current psychedelics environment as well as some of the regulatory hurdles related to getting product to market. Throughout, Jeff discusses the current prospects for not only Psyched Wellness, but …